Profile - To The Moon

JohnDiDaDi

Posts · 112Posts · 112
Following · 0Following · 0
Followers · 0Followers · 0

- JohnDiDaDiJohnDiDaDi
  ·2023-05-17
  good to read
  These 11 Regional Bank Stocks Are Deeply Undervalued and Should Survive the Intense Pressures Hitting the Sector Today
  A string of recent bank failures has crushed shares of smaller US banks over the last three months.M
  These 11 Regional Bank Stocks Are Deeply Undervalued and Should Survive the Intense Pressures Hitting the Sector Today
  161 Comment
  4
  Share
  Report
- JohnDiDaDiJohnDiDaDi
  ·2023-04-09
  Sharing this great article
  BofA Securities Out With Top “Strong Buy” Stock Ideas for Q2 2023
  Incredibly, the first quarter is now history, after a volatile 90 days to start 2023 that saw the re
  BofA Securities Out With Top “Strong Buy” Stock Ideas for Q2 2023
  174 Comment
  Like
  Share
  Report
- JohnDiDaDiJohnDiDaDi
  ·2023-03-02
  $SI 20230310 7.0 CALL$ $SI 20230310 7.0 CALL$ not bad la
  281 Comment
  1
  Share
  Report
- JohnDiDaDiJohnDiDaDi
  ·2023-03-02
  $SI 20230310 7.0 CALL$ $SI 20230310 7.0 CALL$ wow
  163 Comment
  4
  Share
  Report
- JohnDiDaDiJohnDiDaDi
  ·2022-10-07
  Great article
  Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market
  Source: ShutterstockIn October 2021, I made a big call on Longeveron (NASDAQ:LGVN) stock, a biotech
  Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market
  270 Comment
  Like
  Share
  Report
- JohnDiDaDiJohnDiDaDi
  ·2022-09-27
  $Proterra Inc.(PTRA)$still got chance?
  174 Comment
  Like
  Share
  Report
- JohnDiDaDiJohnDiDaDi
  ·2021-08-20
  $Lucid Group Inc(LCID)$ oh gosh
  552 Comment
  1
  Share
  Report
- JohnDiDaDiJohnDiDaDi
  ·2021-08-18
  Price target end of week?
  816 1
  1
  Share
  Report
- JohnDiDaDiJohnDiDaDi
  ·2021-08-18
  Up up
  Tesla Stock Sells off While Institutions Continue to Buy.
  Tesla stock has tumbled almost 10% off recent highs but institutions are continuing to buy. In a mar
  Tesla Stock Sells off While Institutions Continue to Buy.
  417 Comment
  1
  Share
  Report
- JohnDiDaDiJohnDiDaDi
  ·2021-08-18
  Lai lai
  @JohnDiDaDi：
  Rebound?
  Rebound?
  387 Comment
  1
  Share
  Report
No following yet

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"3573820977038493","uuid":"3573820977038493","gmtCreate":1610783888879,"gmtModify":1612841207610,"name":"JohnDiDaDi","pinyin":"johndidadi","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/de71e040ea235b301e30935f5399d9d8","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":9,"headSize":147,"tweetSize":112,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":11,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.10.17","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.45%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":1,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":9970606898,"gmtCreate":1684333196014,"gmtModify":1684333200496,"author":{"id":"3573820977038493","authorId":"3573820977038493","name":"JohnDiDaDi","avatar":"https://static.tigerbbs.com/de71e040ea235b301e30935f5399d9d8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573820977038493","authorIdStr":"3573820977038493"},"themes":[],"htmlText":"good to read","listText":"good to read","text":"good to read","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9970606898","repostId":"2335294885","repostType":4,"repost":{"id":"2335294885","pubTimestamp":1684329053,"share":"https://ttm.financial/m/news/2335294885?lang=&edition=fundamental","pubTime":"2023-05-17 21:10","market":"us","language":"en","title":"These 11 Regional Bank Stocks Are Deeply Undervalued and Should Survive the Intense Pressures Hitting the Sector Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2335294885","media":"Markets Insider","summary":"A string of recent bank failures has crushed shares of smaller US banks over the last three months.M","content":"<html><head></head><body><ul><li><p>A string of recent bank failures has crushed shares of smaller US banks over the last three months.</p></li><li><p>Morningstar&#39;s chief US stock strategist says many regional bank stocks are dramatically oversold.</p></li><li><p>Dave Sekera says a handful of bank stocks can be had for less than half of their fair values.</p></li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d697ae700780907706ddf8d56be95f15\" alt=\"A banking crisis has introduced volatility into markets, as well as opportunity. REUTERS/Platiau\" title=\"A banking crisis has introduced volatility into markets, as well as opportunity. REUTERS/Platiau\" tg-width=\"700\" tg-height=\"525\"/><span>A banking crisis has introduced volatility into markets, as well as opportunity. REUTERS/Platiau</span></p><p>If you haven&#39;t heard, bank stocks are having a bad time.</p><p>A series of banks have failed in recent months, hammering shares of financial companies and setting off concerns about a credit crunch that could kick off the recession that investors have been expecting for a year. </p><p>With the entire market keeping an eye out for more signs of bank failure, financial stocks in general and smaller regional banks in particular are getting dumped. The <a href=\"https://laohu8.com/S/EEMA\">iShares</a> US Regional Banks ETF, which tracks the sector, is down 40% over the last six months.</p><p>Morningstar Chief US Market Strategist Dave Sekera says investors are indiscriminately selling the stocks right now, but most of these companies will be on the road to recovery before too long.</p><p>&#34;We think the market is overreacting to short-term pressures and have pushed valuations down too far,&#34; he wrote in a recent note. &#34;The regional banking business model is not broken. Over the long term, these banks will continue to earn returns higher than their cost of capital.&#34;</p><p>The picture isn&#39;t entirely positive. Sekera wrote that earnings for regional banks will continue to decline for the rest of 2023, then start to recover next year. But that&#39;s the extent of the damage he&#39;s expecting.</p><p>With that forthcoming recovery in mind, Sekera also wrote that the following 11 stocks are severely undervalued right now — in fact, he estimates their fair values are 20% to 155% greater than their most-recent closing prices.</p><p>All figures were calculated as of Thursday&#39;s close, and the stocks below are ranked from lowest to highest based on how much upside they have relative to Morningstar&#39;s fair value estimates.</p><h2>11. Regions Financial</h2><p><strong>Ticker</strong>: RF</p><p><strong>Market cap</strong>: $15.0 billion</p><p><strong>Fair value</strong>: $19</p><p><strong>Upside to fair value</strong>: 22.4%</p><h2>10. Frost Bank</h2><p><strong>Ticker</strong>: CFR</p><p><strong>Market cap</strong>: $6.2 billion </p><p><strong>Fair value</strong>: $124</p><p><strong>Upside to fair value</strong>: 29.6%</p><h2>9. M&amp;T Bank</h2><p><strong>Ticker</strong>: MTB</p><p><strong>Market cap</strong>: $18.9 billion</p><p><strong>Fair value</strong>: $163</p><p><strong>Upside to fair value</strong>: 43.9%</p><h2>8. PNC</h2><p><strong>Ticker</strong>: PNC</p><p><strong>Market cap</strong>: $45.2 billion</p><p><strong>Fair value</strong>: $175</p><p><strong>Upside to fair value</strong>: 55.3%</p><h2>7. Fifth Third Bank</h2><p><strong>Ticker</strong>: FITB</p><p><strong>Market cap</strong>: $16.4 billion</p><p><strong>Fair value</strong>: $38</p><p><strong>Upside to fair value</strong>: 60.6%</p><h2>6. Huntington National Bank</h2><p><strong>Ticker</strong>: HBAN</p><p><strong>Market cap</strong>: $13.7 billion</p><p><strong>Fair value</strong>: $15</p><p><strong>Upside to fair value</strong>: 61.6%</p><h2>5. US Bank</h2><p><strong>Ticker</strong>: USB</p><p><strong>Market cap</strong>: $44.8 billion</p><p><strong>Fair value</strong>: $58</p><p><strong>Upside to fair value</strong>: 100.6%</p><h2>4. Truist Financial</h2><p><strong>Ticker</strong>: TFC</p><p><strong>Market cap</strong>: $36.9 billion</p><p><strong>Fair value</strong>: $57</p><p><strong>Upside to fair value</strong>: 112.4%</p><h2>3. <a href=\"https://laohu8.com/S/KEY\">KeyCorp</a></h2><p><strong>Ticker</strong>: KEY</p><p><strong>Market cap</strong>: $8.7 billion</p><p><strong>Fair value</strong>: $21</p><p><strong>Upside to fair value</strong>: 131.0%</p><h2>2. Comerica</h2><p><strong>Ticker</strong>: CMA</p><p><strong>Market cap</strong>: $4.6 billion</p><p><strong>Fair value</strong>: $79</p><p><strong>Upside to fair value</strong>: 141.8%</p><h2>1. Zions Bancorporation</h2><p><strong>Ticker</strong>: ZION</p><p><strong>Market cap</strong>: $3.5 billion</p><p><strong>Fair value</strong>: $58</p><p><strong>Upside to fair value</strong>: 155.7%</p></body></html>","source":"marketsinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 11 Regional Bank Stocks Are Deeply Undervalued and Should Survive the Intense Pressures Hitting the Sector Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 11 Regional Bank Stocks Are Deeply Undervalued and Should Survive the Intense Pressures Hitting the Sector Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-05-17 21:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://markets.businessinsider.com/news/stocks/banking-crisis-regional-financial-stocks-bank-selloff-investing-advice-morningstar-2023-5><strong>Markets Insider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>A string of recent bank failures has crushed shares of smaller US banks over the last three months.Morningstar's chief US stock strategist says many regional bank stocks are dramatically oversold.Dave...</p>\n\n<a href=\"https://markets.businessinsider.com/news/stocks/banking-crisis-regional-financial-stocks-bank-selloff-investing-advice-morningstar-2023-5\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MTB":"美国制商银行","RF":"地区金融","BK4585":"ETF&股票定投概念","FITB":"五三银行","KEY":"KeyCorp","BK4207":"综合性银行","BK4588":"碎股","PNC":"PNC金融","HBAN":"亨廷顿银行","USB":"美国合众银行","BK4211":"区域性银行","CFR":"库伦佛寺银行","ZION":"齐昂银行","BK4112":"金融交易所和数据","TFC":"Truist Financial Corp","BK4589":"SVB概念","CMA":"联信银行"},"source_url":"https://markets.businessinsider.com/news/stocks/banking-crisis-regional-financial-stocks-bank-selloff-investing-advice-morningstar-2023-5","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2335294885","content_text":"A string of recent bank failures has crushed shares of smaller US banks over the last three months.Morningstar's chief US stock strategist says many regional bank stocks are dramatically oversold.Dave Sekera says a handful of bank stocks can be had for less than half of their fair values.A banking crisis has introduced volatility into markets, as well as opportunity. REUTERS/PlatiauIf you haven't heard, bank stocks are having a bad time.A series of banks have failed in recent months, hammering shares of financial companies and setting off concerns about a credit crunch that could kick off the recession that investors have been expecting for a year. With the entire market keeping an eye out for more signs of bank failure, financial stocks in general and smaller regional banks in particular are getting dumped. The iShares US Regional Banks ETF, which tracks the sector, is down 40% over the last six months.Morningstar Chief US Market Strategist Dave Sekera says investors are indiscriminately selling the stocks right now, but most of these companies will be on the road to recovery before too long.\"We think the market is overreacting to short-term pressures and have pushed valuations down too far,\" he wrote in a recent note. \"The regional banking business model is not broken. Over the long term, these banks will continue to earn returns higher than their cost of capital.\"The picture isn't entirely positive. Sekera wrote that earnings for regional banks will continue to decline for the rest of 2023, then start to recover next year. But that's the extent of the damage he's expecting.With that forthcoming recovery in mind, Sekera also wrote that the following 11 stocks are severely undervalued right now — in fact, he estimates their fair values are 20% to 155% greater than their most-recent closing prices.All figures were calculated as of Thursday's close, and the stocks below are ranked from lowest to highest based on how much upside they have relative to Morningstar's fair value estimates.11. Regions FinancialTicker: RFMarket cap: $15.0 billionFair value: $19Upside to fair value: 22.4%10. Frost BankTicker: CFRMarket cap: $6.2 billion Fair value: $124Upside to fair value: 29.6%9. M&T BankTicker: MTBMarket cap: $18.9 billionFair value: $163Upside to fair value: 43.9%8. PNCTicker: PNCMarket cap: $45.2 billionFair value: $175Upside to fair value: 55.3%7. Fifth Third BankTicker: FITBMarket cap: $16.4 billionFair value: $38Upside to fair value: 60.6%6. Huntington National BankTicker: HBANMarket cap: $13.7 billionFair value: $15Upside to fair value: 61.6%5. US BankTicker: USBMarket cap: $44.8 billionFair value: $58Upside to fair value: 100.6%4. Truist FinancialTicker: TFCMarket cap: $36.9 billionFair value: $57Upside to fair value: 112.4%3. KeyCorpTicker: KEYMarket cap: $8.7 billionFair value: $21Upside to fair value: 131.0%2. ComericaTicker: CMAMarket cap: $4.6 billionFair value: $79Upside to fair value: 141.8%1. Zions BancorporationTicker: ZIONMarket cap: $3.5 billionFair value: $58Upside to fair value: 155.7%","news_type":1},"isVote":1,"tweetType":1,"viewCount":161,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9946465022,"gmtCreate":1681025176867,"gmtModify":1681025181515,"author":{"id":"3573820977038493","authorId":"3573820977038493","name":"JohnDiDaDi","avatar":"https://static.tigerbbs.com/de71e040ea235b301e30935f5399d9d8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573820977038493","authorIdStr":"3573820977038493"},"themes":[],"htmlText":"Sharing this great article&nbsp;","listText":"Sharing this great article&nbsp;","text":"Sharing this great article","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9946465022","repostId":"1144582463","repostType":2,"repost":{"id":"1144582463","pubTimestamp":1681022046,"share":"https://ttm.financial/m/news/1144582463?lang=&edition=fundamental","pubTime":"2023-04-09 14:34","market":"us","language":"en","title":"BofA Securities Out With Top “Strong Buy” Stock Ideas for Q2 2023","url":"https://stock-news.laohu8.com/highlight/detail?id=1144582463","media":"24/7 Wall St.","summary":"Incredibly, the first quarter is now history, after a volatile 90 days to start 2023 that saw the re","content":"<html><head></head><body><p>Incredibly, the first quarter is now history, after a volatile 90 days to start 2023 that saw the return of bank failures, rising interest rates, the ongoing war in Ukraine, continued hot and sticky inflation, and a host of additional items that have kept the pressure on stocks. Despite all the negatives, each of the major indexes finished the quarter higher. The tech-heavy Nasdaq led the way, closing up almost 17%, while the S&amp;P 500 scratched out a hard-fought 7% gain and the Dow Jones industrials just barely closed positive, up 0.5%.</p><p style=\"text-align: start;\">The question on the minds of many investors and traders is what the second quarter will bring. With a host of top strategists forecasting recession later this year, and interest rates likely to climb higher, it could be a more-of-the-same quarter. With a reported $508 billion moved to cash during the first quarter, there is plenty of dry powder for stocks, but will the economy remain strong enough for another big move higher?</p><p>BofA Securities is among the first out with top ideas for the second quarter of 2023. Its research report has eight stocks to buy, long ideas that at first glance look like outstanding stock picks for growth investors. It also has two that are expected to underperform, <a href=\"https://laohu8.com/S/KMX\">CarMax Inc.</a> and <a href=\"https://laohu8.com/S/UAL\">United Airlines Holdings Inc.</a>, which could be possible short sale candidates for investors who are more aggressive.</p><p style=\"text-align: start;\">It is important to remember that no single analyst report should be used as a sole basis for any buying or selling decision.</p><h2 style=\"text-align: start;\"><a href=\"https://laohu8.com/S/CUBE\">CubeSmart</a></h2><p style=\"text-align: start;\">This self-storage real estate investment trust (REIT) may seem an odd beneficiary of rising rates, but it is one. CubeSmart (<strong>NASDAQ: CUBE</strong>) is a self-administered, self-managed REIT. Its self-storage properties are designed to offer affordable, easily accessible and secure storage space for residential and commercial customers. According to the Self-Storage Almanac, CubeSmart is one of the top three owners and operators of self-storage properties in the United States.</p><p style=\"text-align: start;\">In a rising rate environment, hard assets like real estate gain in value, and the self-storage REITs are also in a good position as capital expenditures and the need for additional capital are often very low.</p><p style=\"text-align: start;\">Investors receive a 4.13% dividend. The BofA Securities price target for CubeSmart stock is $64, and the consensus target is $51.40.</p><h2 style=\"text-align: start;\"><a href=\"https://laohu8.com/S/FDX\">FedEx</a></h2><p style=\"text-align: start;\">Given the huge increase in internet shopping and sales, the delivery giant has a strong path for growth. FedEx Corp. (<strong>NYSE: FDX</strong>) provides transportation, e-commerce and business services in the United States and internationally.</p><p style=\"text-align: start;\">Its FedEx Express segment offers express transportation, small-package ground delivery and freight transportation services; time-critical transportation services; and cross-border enablement, technology and e-commerce transportation solutions. The FedEx Ground segment provides day-certain delivery services to businesses and residences. And the FedEx Freight segment offers less-than-truckload freight transportation services. As of May 31, 2022, this segment had approximately 30,000 vehicles and 400 service centers.</p><p style=\"text-align: start;\">The FedEx Services segment provides sales, marketing, information technology, communications, customer service, technical support, billing and collection and back-office support services. The Corporate, Other and Eliminations segment offers integrated supply chain management solutions, specialty transportation, customs brokerage and global ocean and air freight forwarding services. It offers document and business services, as well as retail access to its customers for its package transportation businesses.</p><p style=\"text-align: start;\">Shareholders receive a 2.01% dividend. BofA Securities has set its price target at $305. FedEx stock has a consensus target of $239.81.</p><h2 style=\"text-align: start;\"><a href=\"https://laohu8.com/S/FLS\">Flowserve</a></h2><p style=\"text-align: start;\">This company should get a boost from the potential for an improving economy, and the proposed infrastructure build. Flowserve Corp. (<strong>NYSE: FLS</strong>) designs, manufactures, distributes and services industrial flow management equipment in the United States, the Middle East, Europe and elsewhere.</p><p style=\"text-align: start;\">Its Flowserve Pump Division segment offers custom and pre-configured pumps and pump systems, mechanical seals, auxiliary systems, replacement parts, upgrades and related aftermarket services, including installation and commissioning services, seal systems spare parts, repairs, advanced diagnostics, rerate and upgrade solutions, retrofit programs and machining and asset management solutions. It also manufactures a gas-lubricated mechanical seal for use in high-speed compressors for gas pipelines.</p><p>The Flow Control Division segment provides engineered and industrial valve and automation solutions, including isolation and control valves, actuation, controls and related equipment, as well as equipment maintenance services for flow control systems, including advanced diagnostics, repair, installation, commissioning, retrofit programs and field machining capabilities. This segment’s products are used to control, direct and manage the flow of liquids, gases and multiphase fluids.</p><p style=\"text-align: start;\">The company primarily serves oil and gas, chemical and pharmaceuticals, power generation and water management markets, as well as general industries, including mining and ore processing, pulp and paper, food and beverage and other smaller applications. Flowserve distributes its products through direct sales, distributors, and sales representatives.</p><p style=\"text-align: start;\">The dividend yield here is 2.32%. The BofA Securities price objective is $40, while the consensus target is $37.30.</p><h2 style=\"text-align: start;\"><a href=\"https://laohu8.com/S/LW\">Lamb Weston</a></h2><p style=\"text-align: start;\">While somewhat off the radar, this is a safer play for nervous investors. Lamb Weston Holdings Inc. (<strong>NYSE: LW</strong>) produces, distributes and markets value-added frozen potato products to retail and foodservice customers; grocery, mass merchants, club and specialty retailers; and businesses, educational institutions, independent restaurants, regional chain restaurants and convenience stores worldwide.</p><p style=\"text-align: start;\">The company offers frozen potatoes, commercial ingredients and appetizers under the Lamb Weston brand, as well as under various customer labels. It also offers its products under its owned or licensed brands, such as Grown in Idaho and Alexia, and other licensed brands, as well as under retailers’ brands. In addition, it engages in the vegetable and dairy businesses.</p><p style=\"text-align: start;\">Lamb Weston stock comes with a 1.07% dividend. The $115 BofA Securities price target compares with a $107.80 consensus target.</p><h2 style=\"text-align: start;\"><a href=\"https://laohu8.com/S/LOW\">Lowe’s</a></h2><p style=\"text-align: start;\">This leading home improvement retailer has a low 6% of foreign sales, and it remains a top pick at Goldman Sachs. Lowe’s Companies Inc (<strong>NYSE: LOW</strong>) has more than 2,000 stores in the United States and Canada. The company has tempered its new store opening plans and is focusing investments on technology and e-commerce capabilities, in addition to improving its retail store productivity.</p><p>Lowe’s offers products for maintenance, repair, remodeling and home decorating. It provides home improvement products under the categories of kitchens and appliances; lumber and building materials; tools and hardware; fashion fixtures; rough plumbing and electrical; lawn and garden; seasonal living; paint; home fashions; storage and cleaning; flooring; millwork; and outdoor power equipment. The company also offers installation services through independent contractors in various product categories.</p><p style=\"text-align: start;\">Top analysts have felt for some time that the company’s tool rental business, which is a $1.5 billion revenue opportunity, is a strong catalyst for multiple expansion.</p><p>Shareholders receive a 2.06% dividend. Lowe’s Companies stock has a $278 target price at BofA Securities.</p><h2 style=\"text-align: start;\"><a href=\"https://laohu8.com/S/NFLX\">Netflix</a></h2><p style=\"text-align: start;\">The entertainment and production giant has evolved in a big way over the past few years and could be ready to soar higher. Netflix Inc. (<strong>NASDAQ: NFLX</strong>) offers TV series, documentaries, feature films and mobile games across various genres and languages. It provides members the ability to receive streaming content through a host of internet-connected devices, including TVs, digital video players, television set-top boxes and mobile devices. The company has approximately 231 million paid members in 190 countries.</p><p style=\"text-align: start;\">The BofA report noted this:</p><blockquote>Supported by its world class brand, leading global subscriber base and position as a leading innovator, we believe Netflix is poised to outperform driven by four main drivers: (1) a crackdown on password sharing, (2) the introduction of a value oriented, ad-supported tier which expands the total-addressable-market and monetization, (3) an inflection point in free cash flow, and (4) a significant subscriber runway accelerating by the shift from linear to streaming.</blockquote><p style=\"text-align: start;\">The BofA Securities price target of $410 is well above the $357.23 consensus figure.</p><h2 style=\"text-align: start;\"><a href=\"https://laohu8.com/S/PGR\">Progressive</a></h2><p style=\"text-align: start;\">One business that never seems to struggle is insurance, and this is a leader in the industry. Progressive Corp. (<strong>NYSE: PGR</strong>) provides personal and commercial auto, personal residential and commercial property, general liability, and other specialty property-casualty insurance products and related services in the United States. It operates in three segments.</p><p style=\"text-align: start;\">Its Personal Lines segment writes insurance for personal autos and recreational vehicles. This segment’s products include personal auto insurance and special lines products, including insurance for motorcycles, ATVs, RVs, watercrafts, snowmobiles and related products.</p><p style=\"text-align: start;\">The Commercial Lines segment provides auto-related primary liability and physical damage insurance, and business-related general liability and property insurance for autos, vans, pickup trucks and dump trucks used by small businesses; tractors, trailers and straight trucks primarily used by regional general freight and expeditor-type businesses and long-haul operators; dump trucks, log trucks and garbage trucks used by dirt, sand and gravel, logging and coal-type businesses; and tow trucks and wreckers used in towing services and gas/service station businesses; as well as non-fleet and airport taxis and black-car services.</p><p>The Property segment writes residential property insurance for homes, condos, manufactured homes, and renters, as well as offers personal umbrella insurance, and primary and excess flood insurance. The company also offers policy issuance and claims adjusting services, and it acts as an agent to place business owners’ policies, general and professional liability, and workers’ compensation insurance. In addition, it provides reinsurance services. The company sells its products through independent insurance agencies, as well as directly on the internet through mobile devices and over the phone.</p><p style=\"text-align: start;\">Investors receive just a 0.28% dividend. The BofA Securities price target is $177. The consensus target was last seen at $146.93. On Wednesday, Progressive stock closed at $146.43.</p><h2 style=\"text-align: start;\"><a href=\"https://laohu8.com/S/UNH\">UnitedHealth</a></h2><p>A whopping 45% of fund managers recently surveyed have bought shares of this company. UnitedHealth Group Inc. (<strong>NYSE: UNH</strong>) operates through the following four segments.</p><p>Its UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, midsized employers, small businesses and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children’s Health Insurance Program, and health care programs; and health and dental benefits.</p><p style=\"text-align: start;\">The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement and financial services. This segment serves individuals through programs offered by employers, payers, government entities and directly with the care delivery systems.</p><p style=\"text-align: start;\">The OptumInsight segment offers software and information products, advisory consulting arrangements, and services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies and other organizations.</p><p style=\"text-align: start;\">OptumRx is the segment that provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical. It also develops programs in areas such as step therapy, formulary management, drug adherence and disease/drug therapy management.</p><p style=\"text-align: start;\">UnitedHealth stock investors receive a 1.34% dividend. BofA Securities has a target price of $650, while the consensus target is $596.26.</p><p>These are eight great stock ideas for the second quarter of 2023, along with two potential short sale ideas. All the long picks make good sense for growth investors looking to take some profit and move to new positions. With first-quarter earnings reports right around the corner, buying partial positions makes sense now, to check out not only the results for the quarter but the outlook for the rest of 2023.</p></body></html>","source":"lsy1636345238431","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BofA Securities Out With Top “Strong Buy” Stock Ideas for Q2 2023</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBofA Securities Out With Top “Strong Buy” Stock Ideas for Q2 2023\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-04-09 14:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://247wallst.com/investing/2023/04/06/bofa-securities-out-with-top-strong-buy-stock-ideas-for-q2-2023/><strong>24/7 Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Incredibly, the first quarter is now history, after a volatile 90 days to start 2023 that saw the return of bank failures, rising interest rates, the ongoing war in Ukraine, continued hot and sticky ...</p>\n\n<a href=\"https://247wallst.com/investing/2023/04/06/bofa-securities-out-with-top-strong-buy-stock-ideas-for-q2-2023/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LOW":"劳氏","UNH":"联合健康","NFLX":"奈飞","FDX":"联邦快递"},"source_url":"https://247wallst.com/investing/2023/04/06/bofa-securities-out-with-top-strong-buy-stock-ideas-for-q2-2023/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144582463","content_text":"Incredibly, the first quarter is now history, after a volatile 90 days to start 2023 that saw the return of bank failures, rising interest rates, the ongoing war in Ukraine, continued hot and sticky inflation, and a host of additional items that have kept the pressure on stocks. Despite all the negatives, each of the major indexes finished the quarter higher. The tech-heavy Nasdaq led the way, closing up almost 17%, while the S&P 500 scratched out a hard-fought 7% gain and the Dow Jones industrials just barely closed positive, up 0.5%.The question on the minds of many investors and traders is what the second quarter will bring. With a host of top strategists forecasting recession later this year, and interest rates likely to climb higher, it could be a more-of-the-same quarter. With a reported $508 billion moved to cash during the first quarter, there is plenty of dry powder for stocks, but will the economy remain strong enough for another big move higher?BofA Securities is among the first out with top ideas for the second quarter of 2023. Its research report has eight stocks to buy, long ideas that at first glance look like outstanding stock picks for growth investors. It also has two that are expected to underperform, CarMax Inc. and United Airlines Holdings Inc., which could be possible short sale candidates for investors who are more aggressive.It is important to remember that no single analyst report should be used as a sole basis for any buying or selling decision.CubeSmartThis self-storage real estate investment trust (REIT) may seem an odd beneficiary of rising rates, but it is one. CubeSmart (NASDAQ: CUBE) is a self-administered, self-managed REIT. Its self-storage properties are designed to offer affordable, easily accessible and secure storage space for residential and commercial customers. According to the Self-Storage Almanac, CubeSmart is one of the top three owners and operators of self-storage properties in the United States.In a rising rate environment, hard assets like real estate gain in value, and the self-storage REITs are also in a good position as capital expenditures and the need for additional capital are often very low.Investors receive a 4.13% dividend. The BofA Securities price target for CubeSmart stock is $64, and the consensus target is $51.40.FedExGiven the huge increase in internet shopping and sales, the delivery giant has a strong path for growth. FedEx Corp. (NYSE: FDX) provides transportation, e-commerce and business services in the United States and internationally.Its FedEx Express segment offers express transportation, small-package ground delivery and freight transportation services; time-critical transportation services; and cross-border enablement, technology and e-commerce transportation solutions. The FedEx Ground segment provides day-certain delivery services to businesses and residences. And the FedEx Freight segment offers less-than-truckload freight transportation services. As of May 31, 2022, this segment had approximately 30,000 vehicles and 400 service centers.The FedEx Services segment provides sales, marketing, information technology, communications, customer service, technical support, billing and collection and back-office support services. The Corporate, Other and Eliminations segment offers integrated supply chain management solutions, specialty transportation, customs brokerage and global ocean and air freight forwarding services. It offers document and business services, as well as retail access to its customers for its package transportation businesses.Shareholders receive a 2.01% dividend. BofA Securities has set its price target at $305. FedEx stock has a consensus target of $239.81.FlowserveThis company should get a boost from the potential for an improving economy, and the proposed infrastructure build. Flowserve Corp. (NYSE: FLS) designs, manufactures, distributes and services industrial flow management equipment in the United States, the Middle East, Europe and elsewhere.Its Flowserve Pump Division segment offers custom and pre-configured pumps and pump systems, mechanical seals, auxiliary systems, replacement parts, upgrades and related aftermarket services, including installation and commissioning services, seal systems spare parts, repairs, advanced diagnostics, rerate and upgrade solutions, retrofit programs and machining and asset management solutions. It also manufactures a gas-lubricated mechanical seal for use in high-speed compressors for gas pipelines.The Flow Control Division segment provides engineered and industrial valve and automation solutions, including isolation and control valves, actuation, controls and related equipment, as well as equipment maintenance services for flow control systems, including advanced diagnostics, repair, installation, commissioning, retrofit programs and field machining capabilities. This segment’s products are used to control, direct and manage the flow of liquids, gases and multiphase fluids.The company primarily serves oil and gas, chemical and pharmaceuticals, power generation and water management markets, as well as general industries, including mining and ore processing, pulp and paper, food and beverage and other smaller applications. Flowserve distributes its products through direct sales, distributors, and sales representatives.The dividend yield here is 2.32%. The BofA Securities price objective is $40, while the consensus target is $37.30.Lamb WestonWhile somewhat off the radar, this is a safer play for nervous investors. Lamb Weston Holdings Inc. (NYSE: LW) produces, distributes and markets value-added frozen potato products to retail and foodservice customers; grocery, mass merchants, club and specialty retailers; and businesses, educational institutions, independent restaurants, regional chain restaurants and convenience stores worldwide.The company offers frozen potatoes, commercial ingredients and appetizers under the Lamb Weston brand, as well as under various customer labels. It also offers its products under its owned or licensed brands, such as Grown in Idaho and Alexia, and other licensed brands, as well as under retailers’ brands. In addition, it engages in the vegetable and dairy businesses.Lamb Weston stock comes with a 1.07% dividend. The $115 BofA Securities price target compares with a $107.80 consensus target.Lowe’sThis leading home improvement retailer has a low 6% of foreign sales, and it remains a top pick at Goldman Sachs. Lowe’s Companies Inc (NYSE: LOW) has more than 2,000 stores in the United States and Canada. The company has tempered its new store opening plans and is focusing investments on technology and e-commerce capabilities, in addition to improving its retail store productivity.Lowe’s offers products for maintenance, repair, remodeling and home decorating. It provides home improvement products under the categories of kitchens and appliances; lumber and building materials; tools and hardware; fashion fixtures; rough plumbing and electrical; lawn and garden; seasonal living; paint; home fashions; storage and cleaning; flooring; millwork; and outdoor power equipment. The company also offers installation services through independent contractors in various product categories.Top analysts have felt for some time that the company’s tool rental business, which is a $1.5 billion revenue opportunity, is a strong catalyst for multiple expansion.Shareholders receive a 2.06% dividend. Lowe’s Companies stock has a $278 target price at BofA Securities.NetflixThe entertainment and production giant has evolved in a big way over the past few years and could be ready to soar higher. Netflix Inc. (NASDAQ: NFLX) offers TV series, documentaries, feature films and mobile games across various genres and languages. It provides members the ability to receive streaming content through a host of internet-connected devices, including TVs, digital video players, television set-top boxes and mobile devices. The company has approximately 231 million paid members in 190 countries.The BofA report noted this:Supported by its world class brand, leading global subscriber base and position as a leading innovator, we believe Netflix is poised to outperform driven by four main drivers: (1) a crackdown on password sharing, (2) the introduction of a value oriented, ad-supported tier which expands the total-addressable-market and monetization, (3) an inflection point in free cash flow, and (4) a significant subscriber runway accelerating by the shift from linear to streaming.The BofA Securities price target of $410 is well above the $357.23 consensus figure.ProgressiveOne business that never seems to struggle is insurance, and this is a leader in the industry. Progressive Corp. (NYSE: PGR) provides personal and commercial auto, personal residential and commercial property, general liability, and other specialty property-casualty insurance products and related services in the United States. It operates in three segments.Its Personal Lines segment writes insurance for personal autos and recreational vehicles. This segment’s products include personal auto insurance and special lines products, including insurance for motorcycles, ATVs, RVs, watercrafts, snowmobiles and related products.The Commercial Lines segment provides auto-related primary liability and physical damage insurance, and business-related general liability and property insurance for autos, vans, pickup trucks and dump trucks used by small businesses; tractors, trailers and straight trucks primarily used by regional general freight and expeditor-type businesses and long-haul operators; dump trucks, log trucks and garbage trucks used by dirt, sand and gravel, logging and coal-type businesses; and tow trucks and wreckers used in towing services and gas/service station businesses; as well as non-fleet and airport taxis and black-car services.The Property segment writes residential property insurance for homes, condos, manufactured homes, and renters, as well as offers personal umbrella insurance, and primary and excess flood insurance. The company also offers policy issuance and claims adjusting services, and it acts as an agent to place business owners’ policies, general and professional liability, and workers’ compensation insurance. In addition, it provides reinsurance services. The company sells its products through independent insurance agencies, as well as directly on the internet through mobile devices and over the phone.Investors receive just a 0.28% dividend. The BofA Securities price target is $177. The consensus target was last seen at $146.93. On Wednesday, Progressive stock closed at $146.43.UnitedHealthA whopping 45% of fund managers recently surveyed have bought shares of this company. UnitedHealth Group Inc. (NYSE: UNH) operates through the following four segments.Its UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, midsized employers, small businesses and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children’s Health Insurance Program, and health care programs; and health and dental benefits.The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement and financial services. This segment serves individuals through programs offered by employers, payers, government entities and directly with the care delivery systems.The OptumInsight segment offers software and information products, advisory consulting arrangements, and services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies and other organizations.OptumRx is the segment that provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical. It also develops programs in areas such as step therapy, formulary management, drug adherence and disease/drug therapy management.UnitedHealth stock investors receive a 1.34% dividend. BofA Securities has a target price of $650, while the consensus target is $596.26.These are eight great stock ideas for the second quarter of 2023, along with two potential short sale ideas. All the long picks make good sense for growth investors looking to take some profit and move to new positions. With first-quarter earnings reports right around the corner, buying partial positions makes sense now, to check out not only the results for the quarter but the outlook for the rest of 2023.","news_type":1},"isVote":1,"tweetType":1,"viewCount":174,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9940146047,"gmtCreate":1677769754889,"gmtModify":1677770432614,"author":{"id":"3573820977038493","authorId":"3573820977038493","name":"JohnDiDaDi","avatar":"https://static.tigerbbs.com/de71e040ea235b301e30935f5399d9d8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573820977038493","authorIdStr":"3573820977038493"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/OPT/SI 20230310 7.0 CALL\">$SI 20230310 7.0 CALL$ </a><a href=\"https://ttm.financial/OPT/SI 20230310 7.0 CALL\">$SI 20230310 7.0 CALL$&nbsp;</a> &nbsp;not bad la&nbsp;","listText":"<a href=\"https://ttm.financial/OPT/SI 20230310 7.0 CALL\">$SI 20230310 7.0 CALL$ </a><a href=\"https://ttm.financial/OPT/SI 20230310 7.0 CALL\">$SI 20230310 7.0 CALL$&nbsp;</a> &nbsp;not bad la&nbsp;","text":"$SI 20230310 7.0 CALL$ $SI 20230310 7.0 CALL$ not bad la","images":[{"img":"https://community-static.tradeup.com/news/ae118d03b47505f2bc2fb3a148e938a9","width":"1080","height":"2182"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9940146047","isVote":1,"tweetType":1,"viewCount":281,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9940143156,"gmtCreate":1677769201975,"gmtModify":1677769205168,"author":{"id":"3573820977038493","authorId":"3573820977038493","name":"JohnDiDaDi","avatar":"https://static.tigerbbs.com/de71e040ea235b301e30935f5399d9d8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573820977038493","authorIdStr":"3573820977038493"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/OPT/SI 20230310 7.0 CALL\">$SI 20230310 7.0 CALL$ </a><a href=\"https://ttm.financial/OPT/SI 20230310 7.0 CALL\">$SI 20230310 7.0 CALL$&nbsp;</a> &nbsp;wow","listText":"<a href=\"https://ttm.financial/OPT/SI 20230310 7.0 CALL\">$SI 20230310 7.0 CALL$ </a><a href=\"https://ttm.financial/OPT/SI 20230310 7.0 CALL\">$SI 20230310 7.0 CALL$&nbsp;</a> &nbsp;wow","text":"$SI 20230310 7.0 CALL$ $SI 20230310 7.0 CALL$ wow","images":[{"img":"https://community-static.tradeup.com/news/31a6fb8ffd05a7587f73a43ea9c1fba6","width":"1080","height":"2182"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9940143156","isVote":1,"tweetType":1,"viewCount":163,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9914002728,"gmtCreate":1665120036164,"gmtModify":1676537561020,"author":{"id":"3573820977038493","authorId":"3573820977038493","name":"JohnDiDaDi","avatar":"https://static.tigerbbs.com/de71e040ea235b301e30935f5399d9d8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573820977038493","authorIdStr":"3573820977038493"},"themes":[],"htmlText":"Great article","listText":"Great article","text":"Great article","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9914002728","repostId":"2273828361","repostType":2,"repost":{"id":"2273828361","pubTimestamp":1665108107,"share":"https://ttm.financial/m/news/2273828361?lang=&edition=fundamental","pubTime":"2022-10-07 10:01","market":"us","language":"en","title":"Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2273828361","media":"InvestorPlace","summary":"Source: ShutterstockIn October 2021, I made a big call on Longeveron (NASDAQ:LGVN) stock, a biotech ","content":"<html><head></head><body><p><img src=\"https://static.tigerbbs.com/11abc7bc1b026070774bd992fe8fb96d\" tg-width=\"768\" tg-height=\"432\" referrerpolicy=\"no-referrer\"/></p><p>Source: Shutterstock</p><p>In October 2021, I made a big call on <b>Longeveron</b> (NASDAQ:<b>LGVN</b>) stock, a biotech firm working on a promising Alzheimer’s therapy.</p><p>Within six weeks, shares had risen over 11x… a stunning 1,000% return!</p><p>My secret?</p><p>I noticed that the biotech’s CFO was quietly buying shares in the company.</p><p>“With clinical results due within the next month, Longeveron’s executives are likely using their knowledge of the Aging Frailty study to predict a strong outcome in the Alzheimer’s trial.”</p><p>Just a month later, the company would announce some unexpectedly good news: The U.S. Food and Drug Administration (FDA) approved Longeveron’s Lomecel-B for use!</p><h2>The Secret to Finding 1,000% Winners</h2><p>It turns out that Longeveron’s management aren’t the only ones who are suspiciously good at timing their company’s stock.</p><p>A study by MIT researchers found that insider transactions in the U.S. would have turned $10,000 into $156,000 over their study period, compared to around $50,300 in the <b>S&amp;P 500</b>.</p><p>That’s because insiders often act on privileged information, both knowingly and unknowingly. If sales figures are doing well… or patients are responding well to clinical trials… they don’t need the “official” SEC filings to decide to buy.</p><p>Some call it a total scam.</p><p>And I get it. SEC rules around insider transactions are surprisingly lax; if a CEO sees a new product performing well or is on the cusp of making a massive deal, it’s often entirely legal to trade on that information. In 2018, <b>Tesla</b> (NASDAQ:<b>TSLA</b>) CEO Elon Musk bought $25 million of his company’s shares while details of a massive $2 billion capital raise were still under wraps.</p><p>TSLA shares would rise 206% within a year.</p><p>But as I’ve long said, <b>if you can’t beat ’em, you might as well join</b>. If the world’s richest man generated an extra $75 million along the way by using privileged information, isn’t it fair to follow his steps?</p><p>It’s a strategy I’ve called the <b>Insider Track</b>.</p><h2>The Best Time to Buy… Is in a Bear Market</h2><p>The Insider Track strategy has provenly strong results. Since January 2009, C-Suite buying has generated an annualized return of 20.8%, according to tracking site TipRanks. And in the past week alone, insiders have snapped up $45 million of their corporate shares.</p><p>These amounts are admittedly smaller than in previous declines. In May 2020, insiders bought a stunning $161 million of shares after the Covid-19 slump. And today, many sectors are doing worse than in 2020 because of higher inflation and rising rates.</p><p>But some American businesses are still humming along. Here are 15 stocks where insiders act as if they know something the market doesn’t.</p><h2>Top Market Timers</h2><p>One of the best <b>Insider Track</b> strategies involves mimicking the trades of particularly successful insiders. These are investment firms, CEOs and company owners that have an unusual ability to buy the dips.</p><p><b>B. Riley Financial</b>. The boutique investment bank has a strong track record in trading the companies it owns.</p><ul><li><b>Lazydays Holdings</b> (NASDAQ:<b>LAZY</b>). In July, the investment bank bought over 10,000 LAZY shares in the $12 range before the CEO announced “remarkable performance” figures. Shares would jump to $17.50. Recent market wobbles have sent LAZY back to the $12 range – an opportunity B. Riley has used to add another 20,000 shares.</li></ul><p><b>Opaleye LLC</b>. Opaleye LLC has a notable record of picking biotech winners. A $16 million investment in <b>Travere Therapeutics</b> (NASDAQ:<b>TVTX</b>) in 2014 is now worth almost $50 million, and a smaller investment in <b><a href=\"https://laohu8.com/S/OCUL\">Ocular Therapeutix</a></b> (NASDAQ:<b>OCUL</b>) netted an even more significant 400% return in 2020. Now, the company has added shares in:</p><ul><li><b>TELA Bio</b> (NASDAQ:<b><u>TELA</u></b>). Since June, Opaleye has snapped up shares of TELA in the $5.75 to $8.25 range in seven transactions. The commercial-stage medical tech firm produces products for soft-tissue reconstruction in hernias, plastic and reconstructive surgery. The firm has a stable business, so Opaleye is likely buying as a valuation play.</li><li><b>TRACON Pharmaceuticals</b> (NASDAQ:<b>TCON</b>). The biotech research firm is developing an oncology drug that targets the PD-L1 antibody, a known pathway under study by other large cancer research firms. The drug is now in its pivotal Phase 2 trial, giving the stock a significant upside on any good news.</li><li><b>Protara Therapeutics</b> (NASDAQ:<b>TARA</b>). The New York-based biopharma company has two development programs in its pipeline. OK-432 is designed to treat lymphatic malformations, a common disease thought to affect 1 in every 4,000 live births, and TARA-002, a treatment for bladder cancer. Opaleye’s 19,400 share addition in mid-September brings its stake to 2,575,77, a significant stake in a company with potential blockbusters in its pipeline.</li></ul><h3>Biotech Stocks</h3><p>Opaleye’s investments represent bets on biotech — some of the hardest decisions for the <b>Insider Track</b> strategy. Many of these R&amp;D firms are riding on a single drug candidate, meaning one failed trial will send the stock to zero. And as outsiders, we can’t tell the difference between opportunistic insider buying versus “pump and dumps.”</p><p><i>But biotechs are also some of the most lucrative bets, as Longeveron shows.</i></p><p>That’s because biotech executives often know clinical trial results years before the studies publish official results. If half of your patients suddenly stop developing cancers, you don’t need to be a rocket scientist (or a biotech CEO) to realize your therapy is probably outperforming the placebo in your double-blind study. These executives are also generally aware of how discussions with healthcare regulators are progressing.</p><p>That leads us to three biotech stocks where insiders have recently bought significant stakes.</p><p><b>Zivo Bioscience</b> (NASDAQ:<b>ZIVO</b>). Director Christopher Maggiore joined CEO John Payne in buying shares in the $3.50 range after shares fell from over $5. The company develops algae-based products for food-based ingredients and has a market value of under $30 million. It’s a risky bet, but Mr. Maggiore’s $25,000 share purchase suggests he knows something we don’t.</p><p><b><a href=\"https://laohu8.com/S/BTTX\">Better Therapeutics</a></b> (NASDAQ:<b>BTTX</b>). The prescription digital therapeutics firm has seen a recent rash of cluster buying. The company’s CEO, CFO and a 10% owner have added $304,000 to their stakes since Sept. 12, a telling sign that the firm might have stumbled on a working therapy. Management previously indicated that its most promising candidate, BT-001, could advance pivotal trials this year or early 2023. Trades centered in the $2 range.</p><p><b>TransCode Therapeutics</b> (NASDAQ:<b>RNAZ</b>). The firm’s CEO and 10% owner added 20,000 shares on Sept. 14, raising his stake to 893,114 shares. The firm has a single therapeutic candidate, TTDX-MC138, in its pipeline designed to treat metastatic cancer. The drug is in preclinical trials, meaning that any good news could send shares up several times over.</p><h2>Insider Purchases of Public Offerings</h2><p>Public offerings are one of the best ways to understand insider sentiment. Management can spend months preparing these offerings, giving them a clear idea of the issue’s true value as Elon Musk demonstrated in his 2019 TSLA purchase.</p><p><b>Larimar Therapeutics</b> (NASDAQ:<b>LRMR</b>). The biotech’s CEO, CFO and two directors bought a combined 5.1 million shares at the firm’s public offering price of $3.15. Larimar’s lead candidate CTI-1601 is currently undergoing Phase 1 clinical trials for Friedreich’s ataxia, a rare genetic disease. Shares would jump 15.5% the following day after the FDA lifted a hold on the trial, but such broad insider purchasing often indicates more potential gains.</p><p><b>LinkBancorp</b> (NASDAQ:<b><u>LNKB</u></b>). The Pennsylvania-based bank saw 17 executives and directors buy shares in its recent $7.50 public offer – the same price it offered public investors. One director added 80,000 shares in the $7.70 range after prices jumped in first-day trading. Though outsiders won’t get a clear look into the bank’s recent merger with Gratz until next quarter, insiders seem to believe there’s no need to wait for official pro forma figures to buy at market prices.</p><h2>Cluster Buying</h2><p>Finally, corporate executives often act together in buying company shares. These are some of the most compelling <b>Insider Track</b> investments to make.</p><p><b>Macerich</b> (NYSE:<b>MAC</b>). The Santa Monica-based homebuilder saw six insiders buy 104,617 shares this week, including the company’s CEO, president, CFO, and head of leasing. The company now trades at 0.6x book value, significantly below its historical average of 1.6x.</p><p><b>Liquidia</b> (NASDAQ:<b>LQDA</b>). Shares of the biopharmaceutical company sank 37% in late August after losing a patent battle with <b>United Therapeutics</b> (NASDAQ:<b>UTHR</b>) Insiders, however, have recently bought shares in the $5.50-$6.00 range, including its CEO (45,747 shares), CFO (8000 shares), Commercial SVP (2,160 shares), COO (1,918 shares) and 10% owner <b>Caligan Partners</b> (250,000 shares).</p><p><b><a href=\"https://laohu8.com/S/MFA\">MFA Financial</a></b> (NYSE:<b>MFA</b>). Between Sept. 14-15, the financial firm’s CEO, CFO, Co-CIO and a director added over 10,000 shares to their already-substantial holdings. Shares of MFA have fallen 55% this year over fears about its lending portfolio, particularly from its high exposure to residential whole loans. Insiders are buying shares as if the worries are wildly overblown.</p><p><b>B. Riley Financial</b> (NASDAQ:<b>RILY</b>). The company’s CEO Andrew Moore and director Randall Paulson joined owner Bryant Riley this week in snapping up a combined 48,400 shares in the boutique investment banking and wealth management firm. Shares currently trade at under 6x price-earnings, making it one of the cheapest investment banks by that metric.</p><p><b>Tilly’s</b> (NYSE:<b>TLYS</b>). The CFO of the youth-oriented shoe and clothing retailer joined two directors this week in buying up shares in the $6-$7 range. Tilly’s recent share slide now prices the retailer at 1.5x EV/EBITDA (enterprise value to earnings before interest, taxes, depreciation and amortization), around a quarter of its usual value. Given its high operating leverage, a stronger-than-expected back-to-school season could send shares up 2x-3x from current prices.</p><p><b>L. B. Foster</b> (NASDAQ:<b>FSTR</b>). The CEO and CFO of the railroad infrastructure firm bought another 4,000 shares on Sept. 13, increasing their combined stake to over 110,000. The company trades for under 0.6x price-book, its lowest valuation since February 2016. The last time that happened, shares would recover within two months, earning investors a 60% return within two months and another 30% return within the next 10.</p><h2>Conclusion: How to Use the Insider Track</h2><p>Not all insider purchases are created equal.</p><p>Some industries like biotech, metals and mining are a treasure trove of opportunity. Executives are often aware of promising new drugs and dig sites long before the companies are required by the SEC to disclose material findings.</p><p>Following executives in other sectors comes with greater risks. Are insiders at <b>Exxon</b> (NYSE:<b>XOM</b>) buying because of an unannounced deal? Or are they blindly speculating on oil prices instead?</p><p>That’s why I tend to avoid companies like <b>HighPeak Energy</b> (NASDAQ:<b>HPK</b>), <b>U.S. Energy Corp</b> (NASDAQ:<b>USEG</b>) and <b>Stronghold Digital Mining</b> (NASDAQ:<b>SDIG</b>) — firms that also recently announced insider purchases. Shares in these firms more closely track the price of oil and <b>Bitcoin</b> (<b><u>BTC-USD</u></b>) – assets that no executive can predict.</p><p>Instead, I focus on bets with particularly opaque financials and high operating leverage. And though every investment requires deeper research before jumping in, the <b>Insider Track</b> provides us with a strong starting point to beating the markets.</p></body></html>","source":"investorplace","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInsider Buying 2022: 15 Stocks to Bet On Despite the Bear Market\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-10-07 10:01 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/10/insider-buying-2022-15-stocks-to-bet-on-despite-the-bear-market/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Source: ShutterstockIn October 2021, I made a big call on Longeveron (NASDAQ:LGVN) stock, a biotech firm working on a promising Alzheimer’s therapy.Within six weeks, shares had risen over 11x… a ...</p>\n\n<a href=\"https://investorplace.com/2022/10/insider-buying-2022-15-stocks-to-bet-on-despite-the-bear-market/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MAC":"马塞里奇房产","BK4198":"医疗保健用品","TSLA":"特斯拉","TLYS":"Tilly’s","FSTR":"LB福斯特","BK4551":"寇图资本持仓","MFA":"MFA Financial","BK4574":"无人驾驶","TQQQ":"纳指三倍做多ETF","USEG":"美国能源","ZIVO":"Zivo Bioscience, Inc.","BK4094":"服装零售",".IXIC":"NASDAQ Composite","QQQ":"纳指100ETF","BK4110":"抵押房地产投资信托","BK4099":"汽车制造商","BK4183":"个人用品","BK4511":"特斯拉概念","SDIG":"Stronghold Digital Mining, Inc","TARA":"ArTara Therapeutics, Inc.","BK4127":"投资银行业与经纪业","LRMR":"Larimar Therapeutics, Inc.","RILY":"B. Riley Financial, Inc.","HPK":"Highpeak Energy Acquisition Corp","BK4539":"次新股","BK4213":"石油与天然气的勘探与生产","BK4516":"特朗普概念","BTTX":"Better Therapeutics, Inc.","BK4023":"应用软件","BK4532":"文艺复兴科技持仓","BK4570":"地缘局势概念股","TVTX":"Travere Therapeutics, Inc.","XOM":"埃克森美孚","BK4214":"汽车零售","BK4534":"瑞士信贷持仓","BK4139":"生物科技","SQQQ":"纳指三倍做空ETF","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4555":"新能源车","TELA":"TELA Bio, Inc.","BK4527":"明星科技股","LQDA":"Liquidia Technologies Inc","QLD":"纳指两倍做多ETF","BK4080":"零售业房地产投资信托","RNAZ":"TransCode Therapeutics  Inc.","PSQ":"纳指反向ETF","BK4167":"医疗保健技术","OCUL":"Ocular Therapeutix"},"source_url":"https://investorplace.com/2022/10/insider-buying-2022-15-stocks-to-bet-on-despite-the-bear-market/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2273828361","content_text":"Source: ShutterstockIn October 2021, I made a big call on Longeveron (NASDAQ:LGVN) stock, a biotech firm working on a promising Alzheimer’s therapy.Within six weeks, shares had risen over 11x… a stunning 1,000% return!My secret?I noticed that the biotech’s CFO was quietly buying shares in the company.“With clinical results due within the next month, Longeveron’s executives are likely using their knowledge of the Aging Frailty study to predict a strong outcome in the Alzheimer’s trial.”Just a month later, the company would announce some unexpectedly good news: The U.S. Food and Drug Administration (FDA) approved Longeveron’s Lomecel-B for use!The Secret to Finding 1,000% WinnersIt turns out that Longeveron’s management aren’t the only ones who are suspiciously good at timing their company’s stock.A study by MIT researchers found that insider transactions in the U.S. would have turned $10,000 into $156,000 over their study period, compared to around $50,300 in the S&P 500.That’s because insiders often act on privileged information, both knowingly and unknowingly. If sales figures are doing well… or patients are responding well to clinical trials… they don’t need the “official” SEC filings to decide to buy.Some call it a total scam.And I get it. SEC rules around insider transactions are surprisingly lax; if a CEO sees a new product performing well or is on the cusp of making a massive deal, it’s often entirely legal to trade on that information. In 2018, Tesla (NASDAQ:TSLA) CEO Elon Musk bought $25 million of his company’s shares while details of a massive $2 billion capital raise were still under wraps.TSLA shares would rise 206% within a year.But as I’ve long said, if you can’t beat ’em, you might as well join. If the world’s richest man generated an extra $75 million along the way by using privileged information, isn’t it fair to follow his steps?It’s a strategy I’ve called the Insider Track.The Best Time to Buy… Is in a Bear MarketThe Insider Track strategy has provenly strong results. Since January 2009, C-Suite buying has generated an annualized return of 20.8%, according to tracking site TipRanks. And in the past week alone, insiders have snapped up $45 million of their corporate shares.These amounts are admittedly smaller than in previous declines. In May 2020, insiders bought a stunning $161 million of shares after the Covid-19 slump. And today, many sectors are doing worse than in 2020 because of higher inflation and rising rates.But some American businesses are still humming along. Here are 15 stocks where insiders act as if they know something the market doesn’t.Top Market TimersOne of the best Insider Track strategies involves mimicking the trades of particularly successful insiders. These are investment firms, CEOs and company owners that have an unusual ability to buy the dips.B. Riley Financial. The boutique investment bank has a strong track record in trading the companies it owns.Lazydays Holdings (NASDAQ:LAZY). In July, the investment bank bought over 10,000 LAZY shares in the $12 range before the CEO announced “remarkable performance” figures. Shares would jump to $17.50. Recent market wobbles have sent LAZY back to the $12 range – an opportunity B. Riley has used to add another 20,000 shares.Opaleye LLC. Opaleye LLC has a notable record of picking biotech winners. A $16 million investment in Travere Therapeutics (NASDAQ:TVTX) in 2014 is now worth almost $50 million, and a smaller investment in Ocular Therapeutix (NASDAQ:OCUL) netted an even more significant 400% return in 2020. Now, the company has added shares in:TELA Bio (NASDAQ:TELA). Since June, Opaleye has snapped up shares of TELA in the $5.75 to $8.25 range in seven transactions. The commercial-stage medical tech firm produces products for soft-tissue reconstruction in hernias, plastic and reconstructive surgery. The firm has a stable business, so Opaleye is likely buying as a valuation play.TRACON Pharmaceuticals (NASDAQ:TCON). The biotech research firm is developing an oncology drug that targets the PD-L1 antibody, a known pathway under study by other large cancer research firms. The drug is now in its pivotal Phase 2 trial, giving the stock a significant upside on any good news.Protara Therapeutics (NASDAQ:TARA). The New York-based biopharma company has two development programs in its pipeline. OK-432 is designed to treat lymphatic malformations, a common disease thought to affect 1 in every 4,000 live births, and TARA-002, a treatment for bladder cancer. Opaleye’s 19,400 share addition in mid-September brings its stake to 2,575,77, a significant stake in a company with potential blockbusters in its pipeline.Biotech StocksOpaleye’s investments represent bets on biotech — some of the hardest decisions for the Insider Track strategy. Many of these R&D firms are riding on a single drug candidate, meaning one failed trial will send the stock to zero. And as outsiders, we can’t tell the difference between opportunistic insider buying versus “pump and dumps.”But biotechs are also some of the most lucrative bets, as Longeveron shows.That’s because biotech executives often know clinical trial results years before the studies publish official results. If half of your patients suddenly stop developing cancers, you don’t need to be a rocket scientist (or a biotech CEO) to realize your therapy is probably outperforming the placebo in your double-blind study. These executives are also generally aware of how discussions with healthcare regulators are progressing.That leads us to three biotech stocks where insiders have recently bought significant stakes.Zivo Bioscience (NASDAQ:ZIVO). Director Christopher Maggiore joined CEO John Payne in buying shares in the $3.50 range after shares fell from over $5. The company develops algae-based products for food-based ingredients and has a market value of under $30 million. It’s a risky bet, but Mr. Maggiore’s $25,000 share purchase suggests he knows something we don’t.Better Therapeutics (NASDAQ:BTTX). The prescription digital therapeutics firm has seen a recent rash of cluster buying. The company’s CEO, CFO and a 10% owner have added $304,000 to their stakes since Sept. 12, a telling sign that the firm might have stumbled on a working therapy. Management previously indicated that its most promising candidate, BT-001, could advance pivotal trials this year or early 2023. Trades centered in the $2 range.TransCode Therapeutics (NASDAQ:RNAZ). The firm’s CEO and 10% owner added 20,000 shares on Sept. 14, raising his stake to 893,114 shares. The firm has a single therapeutic candidate, TTDX-MC138, in its pipeline designed to treat metastatic cancer. The drug is in preclinical trials, meaning that any good news could send shares up several times over.Insider Purchases of Public OfferingsPublic offerings are one of the best ways to understand insider sentiment. Management can spend months preparing these offerings, giving them a clear idea of the issue’s true value as Elon Musk demonstrated in his 2019 TSLA purchase.Larimar Therapeutics (NASDAQ:LRMR). The biotech’s CEO, CFO and two directors bought a combined 5.1 million shares at the firm’s public offering price of $3.15. Larimar’s lead candidate CTI-1601 is currently undergoing Phase 1 clinical trials for Friedreich’s ataxia, a rare genetic disease. Shares would jump 15.5% the following day after the FDA lifted a hold on the trial, but such broad insider purchasing often indicates more potential gains.LinkBancorp (NASDAQ:LNKB). The Pennsylvania-based bank saw 17 executives and directors buy shares in its recent $7.50 public offer – the same price it offered public investors. One director added 80,000 shares in the $7.70 range after prices jumped in first-day trading. Though outsiders won’t get a clear look into the bank’s recent merger with Gratz until next quarter, insiders seem to believe there’s no need to wait for official pro forma figures to buy at market prices.Cluster BuyingFinally, corporate executives often act together in buying company shares. These are some of the most compelling Insider Track investments to make.Macerich (NYSE:MAC). The Santa Monica-based homebuilder saw six insiders buy 104,617 shares this week, including the company’s CEO, president, CFO, and head of leasing. The company now trades at 0.6x book value, significantly below its historical average of 1.6x.Liquidia (NASDAQ:LQDA). Shares of the biopharmaceutical company sank 37% in late August after losing a patent battle with United Therapeutics (NASDAQ:UTHR) Insiders, however, have recently bought shares in the $5.50-$6.00 range, including its CEO (45,747 shares), CFO (8000 shares), Commercial SVP (2,160 shares), COO (1,918 shares) and 10% owner Caligan Partners (250,000 shares).MFA Financial (NYSE:MFA). Between Sept. 14-15, the financial firm’s CEO, CFO, Co-CIO and a director added over 10,000 shares to their already-substantial holdings. Shares of MFA have fallen 55% this year over fears about its lending portfolio, particularly from its high exposure to residential whole loans. Insiders are buying shares as if the worries are wildly overblown.B. Riley Financial (NASDAQ:RILY). The company’s CEO Andrew Moore and director Randall Paulson joined owner Bryant Riley this week in snapping up a combined 48,400 shares in the boutique investment banking and wealth management firm. Shares currently trade at under 6x price-earnings, making it one of the cheapest investment banks by that metric.Tilly’s (NYSE:TLYS). The CFO of the youth-oriented shoe and clothing retailer joined two directors this week in buying up shares in the $6-$7 range. Tilly’s recent share slide now prices the retailer at 1.5x EV/EBITDA (enterprise value to earnings before interest, taxes, depreciation and amortization), around a quarter of its usual value. Given its high operating leverage, a stronger-than-expected back-to-school season could send shares up 2x-3x from current prices.L. B. Foster (NASDAQ:FSTR). The CEO and CFO of the railroad infrastructure firm bought another 4,000 shares on Sept. 13, increasing their combined stake to over 110,000. The company trades for under 0.6x price-book, its lowest valuation since February 2016. The last time that happened, shares would recover within two months, earning investors a 60% return within two months and another 30% return within the next 10.Conclusion: How to Use the Insider TrackNot all insider purchases are created equal.Some industries like biotech, metals and mining are a treasure trove of opportunity. Executives are often aware of promising new drugs and dig sites long before the companies are required by the SEC to disclose material findings.Following executives in other sectors comes with greater risks. Are insiders at Exxon (NYSE:XOM) buying because of an unannounced deal? Or are they blindly speculating on oil prices instead?That’s why I tend to avoid companies like HighPeak Energy (NASDAQ:HPK), U.S. Energy Corp (NASDAQ:USEG) and Stronghold Digital Mining (NASDAQ:SDIG) — firms that also recently announced insider purchases. Shares in these firms more closely track the price of oil and Bitcoin (BTC-USD) – assets that no executive can predict.Instead, I focus on bets with particularly opaque financials and high operating leverage. And though every investment requires deeper research before jumping in, the Insider Track provides us with a strong starting point to beating the markets.","news_type":1},"isVote":1,"tweetType":1,"viewCount":270,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9918027996,"gmtCreate":1664288476715,"gmtModify":1676537426252,"author":{"id":"3573820977038493","authorId":"3573820977038493","name":"JohnDiDaDi","avatar":"https://static.tigerbbs.com/de71e040ea235b301e30935f5399d9d8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573820977038493","authorIdStr":"3573820977038493"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/PTRA\">$Proterra Inc.(PTRA)$</a>still got chance?&nbsp;","listText":"<a href=\"https://ttm.financial/S/PTRA\">$Proterra Inc.(PTRA)$</a>still got chance?&nbsp;","text":"$Proterra Inc.(PTRA)$still got chance?","images":[{"img":"https://community-static.tradeup.com/news/66b51ac4d684fb5a590dd0e7fcf22f13","width":"1080","height":"1836"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9918027996","isVote":1,"tweetType":1,"viewCount":174,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":836850561,"gmtCreate":1629471289253,"gmtModify":1676530053040,"author":{"id":"3573820977038493","authorId":"3573820977038493","name":"JohnDiDaDi","avatar":"https://static.tigerbbs.com/de71e040ea235b301e30935f5399d9d8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573820977038493","authorIdStr":"3573820977038493"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LCID\">$Lucid Group Inc(LCID)$</a>&nbsp;oh gosh&nbsp;","listText":"<a href=\"https://laohu8.com/S/LCID\">$Lucid Group Inc(LCID)$</a>&nbsp;oh gosh&nbsp;","text":"$Lucid Group Inc(LCID)$ oh gosh","images":[{"img":"https://static.tigerbbs.com/9c5388be68b9cd22f66c32c7ec1f3c3a","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/836850561","isVote":1,"tweetType":1,"viewCount":552,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":833494740,"gmtCreate":1629253782880,"gmtModify":1676529980747,"author":{"id":"3573820977038493","authorId":"3573820977038493","name":"JohnDiDaDi","avatar":"https://static.tigerbbs.com/de71e040ea235b301e30935f5399d9d8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573820977038493","authorIdStr":"3573820977038493"},"themes":[],"htmlText":"Price target end of week?&nbsp;","listText":"Price target end of week?&nbsp;","text":"Price target end of week?","images":[{"img":"https://static.tigerbbs.com/1b221d45a04b2c7729375f13a5ff0833","width":"1080","height":"2528"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/833494740","isVote":1,"tweetType":1,"viewCount":816,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":833494313,"gmtCreate":1629253744132,"gmtModify":1676529980731,"author":{"id":"3573820977038493","authorId":"3573820977038493","name":"JohnDiDaDi","avatar":"https://static.tigerbbs.com/de71e040ea235b301e30935f5399d9d8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573820977038493","authorIdStr":"3573820977038493"},"themes":[],"htmlText":"Up up&nbsp;","listText":"Up up&nbsp;","text":"Up up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/833494313","repostId":"1189114396","repostType":2,"repost":{"id":"1189114396","pubTimestamp":1629247487,"share":"https://ttm.financial/m/news/1189114396?lang=&edition=fundamental","pubTime":"2021-08-18 08:44","market":"us","language":"en","title":"Tesla Stock Sells off While Institutions Continue to Buy.","url":"https://stock-news.laohu8.com/highlight/detail?id=1189114396","media":"TheStreet","summary":"Tesla stock has tumbled almost 10% off recent highs but institutions are continuing to buy.\nIn a mar","content":"<p>Tesla stock has tumbled almost 10% off recent highs but institutions are continuing to buy.</p>\n<p>In a market filled with&nbsp;liquidity, the \"buy the dip mentality\" continues to persist. This appears to be true with Tesla stock and institutions.</p>\n<p><b>Demand for Shares Increases in Q3</b></p>\n<p>Q3 has been on pace to be the first quarter since Q4 2020 to have an overall&nbsp;net inflow&nbsp;of Tesla stock into institutions—those with at least $100 million under management. Currently, there is a net inflow of $7 billion of Tesla stock into institutions. 13F filings were due August 15th to show any quarter-over-quarter changes in Q2, however, institutions can continue to update positions throughout the third quarter.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/373bcfeda661a3fdddb1ad430c075270\" tg-width=\"683\" tg-height=\"604\" width=\"100%\" height=\"auto\"><span>via: marketbeat.com</span></p>\n<p>Of those \"buying the dip\" the Canada Pension Plan Investment Board, increased their position&nbsp;617% quarter-over-quarter&nbsp;for a total of&nbsp;330,196 shares. While this accounts for a small position in the&nbsp;under management&nbsp;for CPPIB, others have made Tesla a larger portion of their portfolio. Australia-based Hyperion Asset Management has also increased its Tesla stock position by over 20%. As a result of the additional shares, Tesla stock is now over 15% of Hyperions portfolio demonstrating more conviction than Cathie Wood'sARKKwith a ~10% allocation to Tesla stock.</p>\n<p><b>A Notable Bear</b></p>\n<p>While not a direct seller of shares, Dr. Michael Burry—famed for hisshortposition against subprime mortgage bonds—has announced in Scion Asset Management's&nbsp;13F&nbsp;the purchase of additional Put Options against Tesla. Scion Asset management has held a bearish Put Option against Tesla since Q1 2021. The aforementioned Put Options&nbsp;— representing 35% of Scion's portfolio and a current market value of ~$731 million—&nbsp;are Scion's largest positions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Stock Sells off While Institutions Continue to Buy.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Stock Sells off While Institutions Continue to Buy.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-18 08:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/tesla/news/institutions-continue-to-buy-q3><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tesla stock has tumbled almost 10% off recent highs but institutions are continuing to buy.\nIn a market filled with liquidity, the \"buy the dip mentality\" continues to persist. This appears to be true...</p>\n\n<a href=\"https://www.thestreet.com/tesla/news/institutions-continue-to-buy-q3\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.thestreet.com/tesla/news/institutions-continue-to-buy-q3","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189114396","content_text":"Tesla stock has tumbled almost 10% off recent highs but institutions are continuing to buy.\nIn a market filled with liquidity, the \"buy the dip mentality\" continues to persist. This appears to be true with Tesla stock and institutions.\nDemand for Shares Increases in Q3\nQ3 has been on pace to be the first quarter since Q4 2020 to have an overall net inflow of Tesla stock into institutions—those with at least $100 million under management. Currently, there is a net inflow of $7 billion of Tesla stock into institutions. 13F filings were due August 15th to show any quarter-over-quarter changes in Q2, however, institutions can continue to update positions throughout the third quarter.\nvia: marketbeat.com\nOf those \"buying the dip\" the Canada Pension Plan Investment Board, increased their position 617% quarter-over-quarter for a total of 330,196 shares. While this accounts for a small position in the under management for CPPIB, others have made Tesla a larger portion of their portfolio. Australia-based Hyperion Asset Management has also increased its Tesla stock position by over 20%. As a result of the additional shares, Tesla stock is now over 15% of Hyperions portfolio demonstrating more conviction than Cathie Wood'sARKKwith a ~10% allocation to Tesla stock.\nA Notable Bear\nWhile not a direct seller of shares, Dr. Michael Burry—famed for hisshortposition against subprime mortgage bonds—has announced in Scion Asset Management's 13F the purchase of additional Put Options against Tesla. Scion Asset management has held a bearish Put Option against Tesla since Q1 2021. The aforementioned Put Options — representing 35% of Scion's portfolio and a current market value of ~$731 million— are Scion's largest positions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":417,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":833495361,"gmtCreate":1629253682253,"gmtModify":1676529980714,"author":{"id":"3573820977038493","authorId":"3573820977038493","name":"JohnDiDaDi","avatar":"https://static.tigerbbs.com/de71e040ea235b301e30935f5399d9d8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573820977038493","authorIdStr":"3573820977038493"},"themes":[],"htmlText":"Lai lai&nbsp;","listText":"Lai lai&nbsp;","text":"Lai lai","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/833495361","repostId":"839025339","repostType":1,"repost":{"id":839025339,"gmtCreate":1629109201321,"gmtModify":1676529932844,"author":{"id":"3573820977038493","authorId":"3573820977038493","name":"JohnDiDaDi","avatar":"https://static.tigerbbs.com/de71e040ea235b301e30935f5399d9d8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573820977038493","authorIdStr":"3573820977038493"},"themes":[],"htmlText":"Rebound?&nbsp;","listText":"Rebound?&nbsp;","text":"Rebound?","images":[{"img":"https://static.tigerbbs.com/9da79e397dc4de27feeb22744bf1973f","width":"1080","height":"2528"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/839025339","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":387,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"following","isTTM":true}